- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Subjects with normal renal function or severe renal impairment (RI) or end stage renal disease (ESRD
Total 443181 results
-
Cerevel Therapeutics, LLCCompleted
-
Hanmi Pharmaceutical Company LimitedCompletedRenal ImpairmentUnited States
-
TakedaCompleted
-
Shanghai Vinnerna Biosciences Co., Ltd.Sponsor GmbHCompletedHealthy Subjects | Subjects With Renal ImpairmentChina
-
Astellas Pharma Global Development, Inc.CompletedRenal Impaired | Gilteritinib | Normal Renal Function | Pharmacokinetics of ASP2215United States, Bulgaria
-
Incyte CorporationCompletedHemodialysis | Renal ImpairmentUnited States
-
TakedaCompleted
-
Kowa Research Institute, Inc.CompletedSevere HypertriglyceridemiaUnited States, Hungary, Belarus, Bulgaria, Czechia, Georgia, Poland, Russian Federation, Ukraine
-
Sunshine Lake Pharma Co., Ltd.Completed
-
AbbVieRoche-GenentechCompletedRenal Impairment | Renal DiseaseUnited States
-
Bristol-Myers SquibbCompleted
-
Lexicon PharmaceuticalsSanofiCompletedType 2 Diabetes Mellitus | Chronic Kidney Disease Stage 3United States, Argentina, Brazil, Canada, Colombia, Germany, Hungary, Israel, Italy, Mexico, Poland, Romania, Russian Federation, South Africa, Spain, Ukraine
-
Novartis PharmaceuticalsCompletedRenal InsufficiencyUnited States, Germany
-
Novartis PharmaceuticalsCompleted
-
Novartis PharmaceuticalsCompleted
-
Spero TherapeuticsCompleted
-
Gilead SciencesCompletedHepatitis C VirusUnited States, New Zealand
-
Novo Nordisk A/SCompletedGrowth Hormone Disorder | Growth Hormone Deficiency in Children | Adult Growth Hormone DeficiencyGermany
-
IpsenCompletedRenal ImpairmentMoldova, Republic of, Belgium, Germany, Romania
-
Centre Hospitalier le MansLe Mans UniversiteWithdrawnFatigue | Chronic Kidney Disease Stage 5 | Chronic Kidney Disease stage3 | Chronic Kidney Failure | Chronic Kidney Disease, Stage 4 (Severe)
-
Gilead SciencesCompletedHCV InfectionUnited States, New Zealand, Germany
-
ObsEva SACompletedSafety and Pharmacokinetics of Linzagolix in Female Subjects With Normal and Impaired Renal FunctionRenal Impairment | Healthy ParticipantsUnited States
-
Heart of England NHS TrustNational Institute for Health Research, United KingdomUnknownCognitive ImpairmentUnited Kingdom
-
Millennium Pharmaceuticals, Inc.CompletedMultiple Myeloma | Advanced Solid TumorsUnited States, Canada
-
GlaxoSmithKlineCompletedSolid TumoursUnited States, Korea, Republic of, Netherlands
-
AbbVieCompletedChronic Hepatitis C | Hepatitis C Virus | Severe Renal Impairment | Compensated Cirrhosis | End-stage Renal Disease
-
AmgenCompletedRenal Impairment | Advanced Solid Tumors | Kidney DiseaseUnited States
-
Novo Nordisk A/SCompleted
-
PfizerCompleted
-
AbbVieCompletedRenal ImpairmentUnited States, New Zealand
-
Alkermes, Inc.CompletedPharmacokinetics and Safety of ALKS 5461 in Subjects With Renal Impairment and Normal Renal FunctionRenal ImpairmentUnited States
-
Jiangsu Hansoh Pharmaceutical Co., Ltd.UnknownType 2 Diabetes MellitusChina
-
Stealth BioTherapeutics Inc.CompletedNormal and Impaired Renal FunctionUnited States
-
Novartis PharmaceuticalsCompletedMild and Moderate Renal ImpairmentRussian Federation, Germany, Serbia
-
Janssen R&D IrelandWithdrawnRenal Impairment | End-stage Renal DiseaseFrance, Spain
-
University of RegensburgCompletedEnd Stage Liver Disease | Impaired Renal FunctionGermany
-
AstraZenecaCompleted
-
Cumberland PharmaceuticalsCompletedKidney Diseases | HyponatremiaUnited States
-
AstraZenecaCompletedRenal Impairment | Healthy Volunteers | Pharmacokinetics | PatientsUnited States
-
Genta IncorporatedCompletedDacarbazine With or Without Oblimersen (G3139) in Treating Patients With Advanced Malignant MelanomaMelanoma (Skin)United States
-
PhaseBio Pharmaceuticals Inc.CompletedDiabetes Mellitus, Type 2United States
-
PfizerCompletedRenal Insufficiency, Chronic | Renal Insufficiency, Acute | Renal Disease, End-StageUnited States
-
NycomedNPS PharmaCompleted
-
CephalonCompleted
-
Anthera PharmaceuticalsTerminatedRenal ImpairmentUnited States
-
GlaxoSmithKlineCompletedDiabetes Mellitus, Type 2 | Renal Insufficiency | Type 2 Diabetes MellitusUnited States